These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34179857)

  • 1. Beyond vaccine hesitancy: time for Africa to expand vaccine manufacturing capacity amidst growing COVID-19 vaccine nationalism.
    Otu A; Osifo-Dawodu E; Atuhebwe P; Agogo E; Ebenso B
    Lancet Microbe; 2021 Aug; 2(8):e347-e348. PubMed ID: 34179857
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa.
    Carcelen AC; Prosperi C; Mutembo S; Chongwe G; Mwansa FD; Ndubani P; Simulundu E; Chilumba I; Musukwa G; Thuma P; Kapungu K; Hamahuwa M; Mutale I; Winter A; Moss WJ; Truelove SA
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-6. PubMed ID: 34227914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccine hesitancy in Africa: a call to action.
    Mutombo PN; Fallah MP; Munodawafa D; Kabel A; Houeto D; Goronga T; Mweemba O; Balance G; Onya H; Kamba RS; Chipimo M; Kayembe JN; Akanmori B
    Lancet Glob Health; 2022 Mar; 10(3):e320-e321. PubMed ID: 34942117
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?
    Wiysonge CS; Ndwandwe D; Ryan J; Jaca A; Batouré O; Anya BM; Cooper S
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-3. PubMed ID: 33684019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Researchers fear growing COVID vaccine hesitancy in developing nations.
    Mallapaty S
    Nature; 2022 Jan; 601(7892):174-175. PubMed ID: 34949861
    [No Abstract]   [Full Text] [Related]  

  • 6. Understanding vaccine hesitancy in COVID-19.
    Trogen B; Pirofski LA
    Med; 2021 May; 2(5):498-501. PubMed ID: 33851144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Source of information on COVID-19 vaccine and vaccine hesitancy among U.S. Medicare beneficiaries.
    Kim J; Kim Y; Li Y
    J Am Geriatr Soc; 2022 Mar; 70(3):677-680. PubMed ID: 34894409
    [No Abstract]   [Full Text] [Related]  

  • 8. Christian nationalism and COVID-19 vaccine hesitancy and uptake.
    Corcoran KE; Scheitle CP; DiGregorio BD
    Vaccine; 2021 Oct; 39(45):6614-6621. PubMed ID: 34629205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccine hesitancy in renal transplant recipients.
    Basic-Jukic N; Furic-Cunko V; Jelakovic B
    Ther Apher Dial; 2022 Apr; 26(2):482-483. PubMed ID: 34719105
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 Vaccine Hesitancy: Why Wait?
    Alexander M
    J Infus Nurs; 2022 Mar-Apr 01; 45(2):71-72. PubMed ID: 35272302
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 vaccines and vaccination: how prepared is Africa?
    Ariyo OE; Oladipo EK; Osasona OG; Obe O; Olomojobi F
    Pan Afr Med J; 2021; 39():107. PubMed ID: 34512843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming COVID-19 vaccine hesitancy: can Australia reach the last 20 percent?
    Kaufman J; Tuckerman J; Danchin M
    Expert Rev Vaccines; 2022 Feb; 21(2):159-161. PubMed ID: 34854334
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 vaccine hesitancy after side effects to the first vaccine: what are our options?
    QJM; 2022 May; 115(5):267. PubMed ID: 35535603
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccine nationalism: a predicament in ending the COVID-19 pandemic.
    Lagman JDN
    J Public Health (Oxf); 2021 Jun; 43(2):e375-e376. PubMed ID: 33730161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Vaccine Hesitancy and How to Address It.
    Rittle C
    Workplace Health Saf; 2022 Feb; 70(2):56-62. PubMed ID: 35073804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety.
    Kricorian K; Civen R; Equils O
    Hum Vaccin Immunother; 2022 Dec; 18(1):1950504. PubMed ID: 34325612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale.
    Kotta I; Kalcza-Janosi K; Szabo K; Marschalko EE
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-10. PubMed ID: 34919494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic.
    Ouyang H; Ma X; Wu X
    Hum Vaccin Immunother; 2022 Dec; 18(1):2013694. PubMed ID: 35172676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A values-driven approach to vaccine hesitancy conversations.
    North ZM; Smit AT; Jenkins LS
    S Afr Fam Pract (2004); 2022 Jan; 64(1):e1-e4. PubMed ID: 35144464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social trauma as a contributory factor in Filipino's vaccine hesitancy.
    Vergara RJD
    J Public Health (Oxf); 2021 Dec; 43(4):e745-e746. PubMed ID: 33837432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.